Some Medicare patients will be able to access to GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more ...

Beginning Wednesday, Medicare will cover GLP-1 drugs for weight loss for the first time, with patients responsible for a $50-a-month co-payment that makes it far cheaper than cash prices without ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

Victor Wembanyama on Catastrophic Loss to Knicks in NBA Finals Game 4: 'It Just Hurts' Wembanyama reflects on the “painful” experience of losing to the Knicks at MSG in Game 4.

The "Meet the Parents" actor is a regular courtside presence for New York Knicks games. Marina Watts is a news writer for Entertainment Weekly with seven years experience covering entertainment, pop ...

LONDON, June 8 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Monday that patients lost 10.5% of their body weight after 26 weeks in a mid-stage trial of its experimental obesity pill, as the ...

Retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and ...

Christine Taylor credited the COVID-19 pandemic for saving her marriage to Ben Stiller after the couple called it quits nearly 10 years ago. “If there’s a silver lining for us during Covid, that was ...

Wegovy is a prescription medication used to help adults and children ages 12 years and older lose weight. It works by copying a natural hormone in the body that helps control hunger. When combined ...

Share on Pinterest A new experimental weight loss drug from Eli Lilly shows dramatic results that rival current GLP-1 drugs and bariatric surgery. Image Credit: Scott Olson/Getty Images Eli Lilly’s ...

New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone.

For decades, people have been told that their weight problems can be solved by math: Calories in, calories out. If weight were a simple math equation, more people would likely be the weight they ...